Within Major Pharmaceutical Preparations industry Lucy Scientific Discovery Inc booked the highest Quick Ratio than Lucy Scientific Discovery Inc in the second quarter 2023. While total ranking remained the same in the Q2 2023 compared to the first quarter 2023 at no. .

Explain Quick Ratio?
How much Cash & cash equivalents LSDI�s has?
What are LSDI�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

LSDI Quick Ratio	(Dec 31 2023) Q2	(Sep 30 2023) Q1	(Jun 30 2023) Q4	(Mar 31 2023) Q3	(Dec 31 2022) Q2
Y / Y Current Liabilities Change	-72.5 %	-67.07 %	-	-	-
Y / Y Cash & cash equivalent Change	-	344.97 %	-	-	-
Quick Ratio MRQ	-	0.11	0.62	0.65	0
LSDI's Total Ranking	#	#	#	#	#
Seq. Current Liabilities Change	8.31 %	-17.87 %	-48.18 %	-40.34 %	29.69 %
Seq. Cash & cash equivalent Change	-	-85.8 %	-51.14 %	13045.31 %	-51.2 %

Quick Ratio second quarter 2023 Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	#
Healthcare Sector	#
Overall Market	#

Quick Ratio Statistics
High	Average	Low
0	0	0

Financial Statements
Lucy Scientific Discovery Inc 's Current Liabilities	$ 2 Millions	Visit LSDI's Balance sheet
Lucy Scientific Discovery Inc 's Cash & cash equivalent	$ 0 Millions	Visit LSDI's Balance sheet
Source of LSDI's Sales		Visit LSDI's Sales by Geography

Cumulative Lucy Scientific Discovery Inc 's Quick Ratio

LSDI's Quick Ratio for the trailling 12 Months

LSDI Quick Ratio	(Dec 31 2023) 12 Months	(Sep 30 2023) 12 Months	(Jun 30 2023) 12 Months	(Mar 31 2023) 12 Months	(Dec 31 2022) 12 Months
Y / Y Current Liabilities TTM Growth	-19 %	180.08 %	-	-	-
Y / Y Cash & cash equivalent TTM Growth	6616.7 %	9943.23 %	-	-	-
Quick Ratio TTM	0.42	0.28	0.22	0.17	0.01
Total Ranking TTM	# 3998	# 3356	# 1892	# 0	# 0
Seq. Current Liabilities TTM Growth	-33.57 %	-19.32 %	13.06 %	33.69 %	129.69 %
Seq. Cash & cash equivalent TTM Growth	-0.49 %	3.56 %	47.76 %	4311.07 %	48.8 %

Quick ratio ranking by company, industry and sector >> Back to LSDI Financial Strength Comparisons >> Go to Compare LSDI Quick Ratio to its Competitors

On the trailing twelve months basis Current Liabilities decreased faster than Lucy Scientific Discovery Inc 's average Cash & cash equivalent, this led to increase in in Lucy Scientific Discovery Inc 's Quick Ratio to 0.42, Quick Ratio remained below LSDI average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 486 other companies have achieved higher Quick Ratio than Lucy Scientific Discovery Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2023 from 3356 to 3998.

Explain Quick Ratio?
How much Cash & cash equivalents LSDI�s has?
What are LSDI�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Major Pharmaceutical Preparations Industry	# 487
Healthcare Sector	# 990
Within the Market	# 3998

trailing twelve months Quick Ratio Statistics
High	Average	Low
0.51	0.42	0.34
(Dec 31 2023)		(Sep 30 2023)

Companies with similar Quick Ratio in the quarter ending Dec 31 2023, within Major Pharmaceutical Preparations Industry

Quick Ratio

Dec 31 2023 MRQ Cash & cash equivalent

Dec 31 2023 MRQ Current Liabilities

Date modified: 2026-09-26T07:42:05+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.